Nicolle Gatto, PhD, FISPE

Chief Science Officer
Aetion, Inc., United States

Aetion Inc (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)Pfizer Inc (Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Applied Sensitivity Analyses in Pharmacoepidemiology Database Studies

  Thursday, August 25, 2022
  2:00 PM – 6:00 PM CEST

• Estimating Real-world Outcomes Under a Rapidly Evolving Treatment Paradigm: Dexamethasone and Inpatient Mortality Among US Hospitalized COVID-19 Patients

  Friday, August 26, 2022
  5:30 PM – 5:45 PM CEST

• Using Real-world Data to Assess Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation in the UK

  Saturday, August 27, 2022
  1:30 PM – 1:45 PM CEST

• Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings

  Sunday, August 28, 2022
  8:45 AM – 9:00 AM CEST